In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved..
The mediator of dioxin toxicity, aryl hydrocarbon receptor (AHR), has also important physiological functions. Selective AHR modulators (SAHRMs) share some effects of dioxins, except for their marked toxicity. We recently characterised toxicologically two novel SAHRMs, prodrugs IMA-08401 and IMA-07101 in rats, demonstrating that they are far less deleterious than the most toxic AHR-agonist, TCDD. Here, we analysed the in vitro toxicity and in silico AHR binding of the respective active, deacetylated metabolites, IMA-06201 (N-ethyl-N-phenyl-5-chloro-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide) and IMA-06504 (N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide). In H4IIE rat hepatoma cells, IMA-06201 and IMA-06504 induced CYP1A1 with comparable potencies and efficacies to those of TCDD. They had little effect on cell viability as assessed by LDH leakage and MTT reduction assays, and were not mutagenic in the Ames test, but IMA-06504 elicited a maximally 2.7-fold increase in micronuclei. Molecular docking simulations showed that similar to TCDD, they occupy the central region of AHR ligand binding cavity. Hence, while showing low to negligible in vitro toxicity, these novel SAHRMs bind to the AHR qualitatively in a similar fashion to TCDD, and appear comparably powerful AHR agonists. Combined with our earlier results demonstrating that they seem considerably less toxic in vivo than TCDD, these compounds are thus highly interesting new SAHRMs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Toxicology in vitro : an international journal published in association with BIBRA - 52(2018) vom: 01. Okt., Seite 178-188 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mahiout, Selma [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AH-receptor |
|---|
| Anmerkungen: |
Date Completed 26.11.2018 Date Revised 26.11.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tiv.2018.06.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM285525174 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM285525174 | ||
| 003 | DE-627 | ||
| 005 | 20231225045631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tiv.2018.06.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0951.xml |
| 035 | |a (DE-627)NLM285525174 | ||
| 035 | |a (NLM)29908305 | ||
| 035 | |a (PII)S0887-2333(18)30259-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mahiout, Selma |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.11.2018 | ||
| 500 | |a Date Revised 26.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a The mediator of dioxin toxicity, aryl hydrocarbon receptor (AHR), has also important physiological functions. Selective AHR modulators (SAHRMs) share some effects of dioxins, except for their marked toxicity. We recently characterised toxicologically two novel SAHRMs, prodrugs IMA-08401 and IMA-07101 in rats, demonstrating that they are far less deleterious than the most toxic AHR-agonist, TCDD. Here, we analysed the in vitro toxicity and in silico AHR binding of the respective active, deacetylated metabolites, IMA-06201 (N-ethyl-N-phenyl-5-chloro-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide) and IMA-06504 (N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide). In H4IIE rat hepatoma cells, IMA-06201 and IMA-06504 induced CYP1A1 with comparable potencies and efficacies to those of TCDD. They had little effect on cell viability as assessed by LDH leakage and MTT reduction assays, and were not mutagenic in the Ames test, but IMA-06504 elicited a maximally 2.7-fold increase in micronuclei. Molecular docking simulations showed that similar to TCDD, they occupy the central region of AHR ligand binding cavity. Hence, while showing low to negligible in vitro toxicity, these novel SAHRMs bind to the AHR qualitatively in a similar fashion to TCDD, and appear comparably powerful AHR agonists. Combined with our earlier results demonstrating that they seem considerably less toxic in vivo than TCDD, these compounds are thus highly interesting new SAHRMs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AH-receptor | |
| 650 | 4 | |a Binding modelling | |
| 650 | 4 | |a IMA-06201 | |
| 650 | 4 | |a IMA-06504 | |
| 650 | 4 | |a Selective modulators | |
| 650 | 4 | |a TCDD | |
| 650 | 7 | |a Quinolines |2 NLM | |
| 650 | 7 | |a Receptors, Aryl Hydrocarbon |2 NLM | |
| 650 | 7 | |a Cytochrome P-450 CYP1A1 |2 NLM | |
| 650 | 7 | |a EC 1.14.14.1 |2 NLM | |
| 700 | 1 | |a Tagliabue, Sara Giani |e verfasserin |4 aut | |
| 700 | 1 | |a Nasri, Atefeh |e verfasserin |4 aut | |
| 700 | 1 | |a Omoruyi, Iyekhoetin Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Pettersson, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Bonati, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Pohjanvirta, Raimo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Toxicology in vitro : an international journal published in association with BIBRA |d 1987 |g 52(2018) vom: 01. Okt., Seite 178-188 |w (DE-627)NLM086842579 |x 1879-3177 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2018 |g day:01 |g month:10 |g pages:178-188 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tiv.2018.06.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2018 |b 01 |c 10 |h 178-188 | ||